Cynthia K Colapinto1, Deborah L O'Connor2, Margaret Sampson3, Brock Williams4, Mark S Tremblay1. 1. Healthy Active Living and Obesity Research, Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario K1H 8L1, Canada University of Ottawa, Ottawa, Ontario, Canada. 2. The Hospital for Sick Children, Toronto, Ontario, Canada University of Toronto, Toronto, Ontario, Canada. 3. Healthy Active Living and Obesity Research, Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario K1H 8L1, Canada. 4. The Hospital for Sick Children, Toronto, Ontario, Canada.
Abstract
BACKGROUND: To examine the relationship between reported high serum or red blood cell (RBC) folate status and adverse health outcomes. METHODS: We systematically searched PubMed/Medline and EMBASE (to May 2013), with no limits by study type, country or population, to identify studies reporting high folate concentrations in association with adverse health outcomes. Two reviewers screened studies and extracted data. Study quality was assessed. RESULTS: We included 51 articles, representing 46 studies and 71 847 participants. Quantiles were used by 96% of studies to identify high folate concentrations. Eighty-three percent of serum folate and 50% of RBC folate studies reported a high folate cutoff that corresponded with a clinically normal concentration. Increasing values of reported high folate concentration did not demonstrate a consistent association with risk of adverse health outcomes. Overall, reported high folate concentrations appeared to be associated with a decreased risk of adverse health outcomes, though substantial methodological heterogeneity precluded complex analyses. CONCLUSIONS: Our interpretation was complicated by methodological variability. High folate cutoffs varied and often corresponded with normal or desirable blood concentrations. In general, a negative association appeared to exist between reported high folate status and adverse health outcomes. Consistent methods and definitions are needed to examine high folate status and ultimately inform public health interventions.
BACKGROUND: To examine the relationship between reported high serum or red blood cell (RBC) folate status and adverse health outcomes. METHODS: We systematically searched PubMed/Medline and EMBASE (to May 2013), with no limits by study type, country or population, to identify studies reporting high folate concentrations in association with adverse health outcomes. Two reviewers screened studies and extracted data. Study quality was assessed. RESULTS: We included 51 articles, representing 46 studies and 71 847 participants. Quantiles were used by 96% of studies to identify high folate concentrations. Eighty-three percent of serum folate and 50% of RBC folate studies reported a high folate cutoff that corresponded with a clinically normal concentration. Increasing values of reported high folate concentration did not demonstrate a consistent association with risk of adverse health outcomes. Overall, reported high folate concentrations appeared to be associated with a decreased risk of adverse health outcomes, though substantial methodological heterogeneity precluded complex analyses. CONCLUSIONS: Our interpretation was complicated by methodological variability. High folate cutoffs varied and often corresponded with normal or desirable blood concentrations. In general, a negative association appeared to exist between reported high folate status and adverse health outcomes. Consistent methods and definitions are needed to examine high folate status and ultimately inform public health interventions.
Authors: Gordon H Guyatt; Andrew D Oxman; Victor Montori; Gunn Vist; Regina Kunz; Jan Brozek; Pablo Alonso-Coello; Ben Djulbegovic; David Atkins; Yngve Falck-Ytter; John W Williams; Joerg Meerpohl; Susan L Norris; Elie A Akl; Holger J Schünemann Journal: J Clin Epidemiol Date: 2011-07-30 Impact factor: 6.437
Authors: Jessica C Kiefte-de Jong; Sarah Timmermans; Vincent W V Jaddoe; Albert Hofman; Henning Tiemeier; Eric A Steegers; Johan C de Jongste; Henriette A Moll Journal: J Nutr Date: 2012-03-07 Impact factor: 4.798
Authors: Ronald G Munger; Tsunenobu Tamura; Kelley E Johnston; Marcia L Feldkamp; Roxane Pfister; Richard Cutler; Maureen A Murtaugh; John C Carey Journal: Birth Defects Res A Clin Mol Teratol Date: 2011-02-02
Authors: Marina Lacasaña; Julia Blanco-Muñoz; Victor H Borja-Aburto; Clemente Aguilar-Garduño; Miguel Rodríguez-Barranco; José A Sierra-Ramirez; Carlos Galaviz-Hernandez; Beatriz Gonzalez-Alzaga; Ricardo Garcia-Cavazos Journal: Public Health Nutr Date: 2012-01-10 Impact factor: 4.022
Authors: T J Hartman; K Woodson; R Stolzenberg-Solomon; J Virtamo; J Selhub; M J Barrett; D Albanes Journal: Am J Epidemiol Date: 2001-04-01 Impact factor: 4.897
Authors: Sari Voutilainen; Jyrki K Virtanen; Tiina H Rissanen; Georg Alfthan; Jari Laukkanen; Kristiina Nyyssönen; Jaakko Mursu; Veli-Pekka Valkonen; Tomi-Pekka Tuomainen; George A Kaplan; Jukka T Salonen Journal: Am J Clin Nutr Date: 2004-08 Impact factor: 7.045
Authors: C S Yajnik; S S Deshpande; A A Jackson; H Refsum; S Rao; D J Fisher; D S Bhat; S S Naik; K J Coyaji; C V Joglekar; N Joshi; H G Lubree; V U Deshpande; S S Rege; C H D Fall Journal: Diabetologia Date: 2007-09-13 Impact factor: 10.122
Authors: Padma Maruvada; Patrick J Stover; Joel B Mason; Regan L Bailey; Cindy D Davis; Martha S Field; Richard H Finnell; Cutberto Garza; Ralph Green; Jean-Louis Gueant; Paul F Jacques; David M Klurfeld; Yvonne Lamers; Amanda J MacFarlane; Joshua W Miller; Anne M Molloy; Deborah L O'Connor; Christine M Pfeiffer; Nancy A Potischman; Joseph V Rodricks; Irwin H Rosenberg; Sharon A Ross; Barry Shane; Jacob Selhub; Sally P Stabler; Jacquetta Trasler; Sedigheh Yamini; Giovanna Zappalà Journal: Am J Clin Nutr Date: 2020-11-11 Impact factor: 7.045